TITLE
Imatinib effects on chronic myelogenous leukemia CD34+ cells

SUMMARY
Comparison of purified bone marrow CD34+ cells from imatinib-treated chronic myelogenous leukemia (CML) patients and healthy donors.

ORGANISM
Homo sapiens

PLATFORM
GPL201 : [HG-Focus] Affymetrix Human HG-Focus Target Array

CITATIONS
Neumann F, Teutsch N, Kliszewski S, Bork S et al. Gene expression profiling of Philadelphia chromosome (Ph)-negative CD34+ hematopoietic stem and progenitor cells of patients with Ph-positive CML in major molecular remission during therapy with imatinib. Leukemia 2005 Mar;19(3):458-60. PMID:Â  15618956

